Feng Wei
Xiamen, 361004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Virus-like particle vaccine targeting meningeal lymphatic vessels via intradural delivery activates anti-glioma immunity.
Journal: Journal of neuro-oncology
Published: February 24, 2026
PRMT5 inhibition suppresses the PI3K/AKT pathway to attenuate vascular smooth muscle cell pathological phenotype in intracranial aneurysm.
Journal: Frontiers in neurology
Published: December 19, 2025
Silencing MALAT1 represses pathological progression, inflammation, and vascular smooth muscle cell phenotype switching by regulating the SEMA3C-mediated Smad pathway in intracranial aneurysms.
Journal: Frontiers in cellular neuroscience
Published: September 16, 2025
Virus-inspired nanocages potentiate glioblastoma sonochemotherapy via structure-function mimicry.
Journal: Acta biomaterialia
Published: July 18, 2025
Correction: Tumor acidity-responsive carrier-free nanodrugs based on targeting activation via ICG-templated assembly for NIR-II imaging-guided photothermal-chemotherapy.
Journal: Biomaterials science
Published: January 07, 2021
Tumor acidity-responsive carrier-free nanodrugs based on targeting activation via ICG-templated assembly for NIR-II imaging-guided photothermal-chemotherapy.
Journal: Biomaterials science
Published: December 15, 2020
Highly Efficient Glioma Targeting of Tat Peptide-TTA1 Aptamer-Polyephylene Glycol-Modified Gelatin-Siloxane Nanoparticles.
Journal: Journal of nanoscience and nanotechnology
Published: February 15, 2018
In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain.
Journal: International journal of nanomedicine
Published: March 10, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026